Given the necessity to devise methods that can be more broadly applied to patients, the present study aims to make a practical molecular classification of endometrial cancer as three subgroups, using MMR and p53 immunohistochemistry (MMR 3-tier classification). This evidence concerns the gene TP53 and endometrial cancer.